Xtl Biopharmaceuticals (XTLB) Enterprise Value Growth (5y) (2014 - 2025)
Xtl Biopharmaceuticals (XTLB) Enterprise Value Growth (5y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 58.32% |
| Jun 30, 2025 | 41.59% |
| Dec 31, 2024 | 29.85% |
| Sep 30, 2024 | 18.01% |
| Jun 30, 2024 | 19.73% |
| Mar 31, 2024 | 14.31% |
| Dec 31, 2023 | 19.95% |
| Sep 30, 2023 | 16.44% |
| Jun 30, 2023 | 15.27% |
| Mar 31, 2023 | 12.29% |
| Dec 31, 2022 | 8.48% |
| Sep 30, 2022 | 18.22% |
| Jun 30, 2022 | 4.00% |
| Mar 31, 2022 | 16.20% |
| Dec 31, 2021 | -20.29% |
| Sep 30, 2021 | -5.33% |
| Jun 30, 2021 | -19.22% |
| Mar 31, 2021 | -1.77% |
| Dec 31, 2020 | -9.56% |
| Sep 30, 2020 | 2.83% |